Skip to main content
Clinical Trials/NCT02700581
NCT02700581
Unknown
Not Applicable

Impact of Moderate Positive End-expiratory Pressure on Hepatic Venous Flow in Patients Undergoing Cardiac Surgery

Konkuk University Medical Center0 sites15 target enrollmentMarch 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Valvular Heart Disease
Sponsor
Konkuk University Medical Center
Enrollment
15
Primary Endpoint
forward hepatic venous flow
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to determine the difference in the impact of moderate positive end-expiratory pressure (PEEP) on hepatic venous flow Doppler in patients undergoing cardiac surgery: conventional versus protective ventilation strategy The possible changes in forward and backward flows (Doppler profiles) of hepatic venous flow at different degrees of PEEP in conventional and protective ventilation strategies are analyzed by using intraoperative transesophageal echocardiography (TEE) in patients undergoing cardiac surgery .

Detailed Description

Following data would be determined after 5 min-exposure volume controlled ventilation employing tidal volume of 10 ml/kg and 6 ml/kg with low PEEP (with 2 mmHg) and moderate PEEP (7 mmHg) during remifentanil-based anesthesia (1.0 mcg/kg/min) for cardiac surgery (n=12) 1. sum of forward hepatic venous flow 2. sum of backward hepatic venous flow 3. peak velocity of diastolic hepatic venous flow 4. lung compliance 5. peak airway pressure 6. mean airway pressure 7. other pressure derived hemodynamic parameters:heart rate; systolic, diastolic, and mean blood pressures; systolic, diastolic, and mean pulmonary artery pressures; central venous pressure (CVP), pulmonary capillary

Registry
clinicaltrials.gov
Start Date
March 2016
End Date
May 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tae-Yop Kim, MD PhD

Professor of Anesthesiology

Konkuk University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing cardiac surgery
  • Patients provide written informed consents

Exclusion Criteria

  • Re-do or tri-do surgery
  • Patients with active infection
  • Patients with endocrine disease
  • Patients ischemic heart disease
  • patients with tricuspid valve regurgitation greater than mild degree

Outcomes

Primary Outcomes

forward hepatic venous flow

Time Frame: 3 min after intervention

Hepatic venous flow Doppler, cm/sec, by transesophageal echocardiography

Secondary Outcomes

  • reversed hepatic venous flow(3 min after intervention)

Similar Trials